Monofilament Testing Best Assesses Foot Ulcer Risk
Monofilament testing (10-g Semmes-Weinstein monofilament) is the single best bedside test to assess this patient's risk of foot ulceration, ideally combined with one additional neurological assessment.
Why Monofilament Testing is the Answer
The 2024 American Diabetes Association guidelines explicitly state that the 10-g monofilament test is one of the most useful and sensitive tests for identifying feet at risk for ulceration 1. This is critical because:
- Peripheral sensory neuropathy (loss of protective sensation/LOPS) is the single most common component cause of foot ulceration, present in 78% of diabetic patients with ulcers 1
- The monofilament test directly assesses LOPS, which is vital to risk stratification
- Clinical examination and the 10-g monofilament test are the two most sensitive tests in identifying the foot at risk for ulceration 1
A landmark prospective multicenter trial of 248 patients followed for 30 months confirmed that clinical examination and the 5.07 Semmes-Weinstein monofilament test achieved 99% sensitivity when used together for predicting foot ulceration 2. The combination of neuropathy disability score and inability to feel the 5.07 monofilament yielded an odds ratio of 26.2 for ulceration 2.
Why the Other Options Are Inferior
Knee Reflex Assessment
While ankle reflexes can be used as a supplementary neurological test alongside monofilament testing 1, knee reflexes are less specific for distal sensory neuropathy affecting the feet. The guidelines recommend monofilament testing as the primary screening tool.
Skin Culture
This assesses infection in an existing ulcer but does not predict future ulcer risk. This patient already has an ulcer, but the question asks about risk assessment, not infection management.
Capillary Refill Time
While capillary refill is mentioned as part of peripheral arterial disease (PAD) screening 1, PAD is less commonly the primary cause of ulceration compared to neuropathy. The guidelines emphasize that neuropathy is present in 78% of ulcers, making it the priority for risk assessment 1.
6-Minute Walk Test
This assesses functional capacity and may indirectly evaluate claudication, but it is not a validated screening tool for foot ulcer risk in diabetes guidelines.
Practical Implementation
The proper technique requires:
- Testing at least 4 plantar sites per foot (typically including the great toe, metatarsal heads)
- Applying the 10-g monofilament perpendicular to the skin until it buckles
- Combining with at least one other test (pinprick, temperature perception, vibration with 128-Hz tuning fork, or ankle reflexes) 1
- Absent monofilament sensation plus one other abnormal test confirms LOPS 1
Clinical Context for This Patient
This 48-year-old man with existing ulceration, diabetes, smoking history, and multiple comorbidities has already demonstrated he is at high risk (IWGDF risk category 3 - history of ulceration). However, monofilament testing remains essential to:
- Confirm the presence and extent of LOPS
- Guide ongoing risk stratification
- Inform preventive strategies for future ulceration
- Determine need for therapeutic footwear and intensive monitoring
All patients with diabetes should undergo comprehensive foot examination including monofilament testing at least annually, and more frequently in high-risk individuals 1.